COVID-19 Vaccine Acceptance and Hesitancy in Low and Middle Income Countries, and Implications for Messaging
Author:
Solís Arce Julio S., Warren Shana S., Meriggi Niccoló F., Scacco Alexandra, McMurry Nina, Voors Maarten, Syunyaev Georgiy, Malik Amyn AbdulORCID, Aboutajdine Samya, Armand Alex, Asad Saher, Augsburg Britta, Bancalari Antonella, Nyqvist Martina Björkman, Borisova Ekaterina, Bosancianu Constantin Manuel, Cheema Ali, Collins Elliott, Farooqi Ahsan Zia, Fracchia Mattia, Guariso Andrea, Hasanain Ali, Kamwesigye Anthony, Kreps Sarah, Levine Madison, Littman Rebecca, Platas Melina, Ramakrishna Vasudha, Shapiro Jacob N., Svensson Jakob, Vernot Corey, Vicente Pedro C., Weissinger Laurin B, Zhang Baobao, Karlan Dean, Callen Michael, Teachout Matthieu, Humphreys Macartan, Omer Saad B.ORCID, Mobarak Ahmed MushfiqORCID
Abstract
AbstractWe analyze COVID-19 vaccine acceptance across 15 survey samples covering ten low- and middle-income countries (LMICs) in Asia, Africa, and South America, Russia (an upper-middle-income country), and the United States, using survey responses from 44,260 individuals. We find considerably higher willingness to take a COVID-19 vaccine in LMIC samples (80% on average) compared to the United States (65%) and Russia (30%). Vaccine acceptance was primarily explained by an interest in personal protection against COVID-19, while concern about side effects was the most commonly expressed reason for reluctance. Health workers were the most trusted sources of information about COVID-19 vaccines. Our findings suggest that prioritizing vaccine distribution to LMICs should yield high returns in promoting global immunization coverage, and that vaccination campaigns in these countries should focus on translating acceptance into uptake. Messaging highlighting vaccine efficacy and safety, delivered by healthcare workers, may be most effective in addressing remaining hesitancy.
Publisher
Cold Spring Harbor Laboratory
Reference69 articles.
1. World Health Organization. Draft landscape and tracker of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (2021). 2. McGill COVID19 Vaccine Tracker Team. COVID-19 Vaccine Tracker. https://covid19.trackvaccines.org/vaccines/ (2021). 3. Wouters, O. J. , et al. Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. The Lancet (2021). 4. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study;The Lancet,2020 5. Ipsos-World Economic Forum. Global attitudes: COVID-19 vaccines. https://www.ipsos.com/en-ro/global-attitudes-covid-19-vaccine-january-2021 (2021).
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|